Showing results (171-180 of 282) with videos related to
Sort By:
Pageof 29
Cancer Reports (Hoboken, N.J.)|September 22, 2024
Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of ChemoimmunotherapyMaría Elena Cabrera, Camila Peña, Valeska Vega, et al.Leukemia Research|January 29, 2013
Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOPJorge J Castillo, Natalie Sinclair, Brady E Beltrán, et al.Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.American Journal of Hematology|October 29, 2014
Extramedullary Waldenström macroglobulinemiaRanjit Banwait, Yosra Aljawai, Joseph Cappuccio, et al.Nature Reviews. Clinical Oncology|November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemiaMichele D Stanchina, Skye Montoya, Alexey V Danilov, et al.Blood Advances|August 22, 2020
Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-upJorge J Castillo, Kirsten Meid, Catherine A Flynn, et al.American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)Steven P Treon, Kirsten Meid, Christina Tripsas, et al.British Journal of Haematology|February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemiaCristina Jiménez, Gloria G Chan, Lian Xu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaSteven P Treon, Kirsten Meid, Joshua Gustine, et al.Pageof 29